amlodipine has been researched along with leptin in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Budak, F; Ersoy, C; Ertürk, E; Imamoğlu, S; Oral, B; Tuncel, E | 1 |
Ahn, JY; Chung, WJ; Han, SH; Koh, KK; Lee, Y; Shin, EK | 1 |
Barkhausen, J; Hübel, N; Mildner, M; Müller-Fielitz, H; Raasch, W; Vogt, FM | 1 |
Khairat, I; Khedr, L; Werida, R | 1 |
2 trial(s) available for amlodipine and leptin
Article | Year |
---|---|
Amlodipine improves endothelial function and metabolic parameters in patients with hypertension.
Topics: Adiponectin; Amlodipine; Antihypertensive Agents; Biomarkers; Cholesterol, HDL; Double-Blind Method; Endothelium, Vascular; Female; Humans; Hypertension; Leptin; Male; Malondialdehyde; Middle Aged; Placebos; Regression Analysis; Resistin; Statistics, Nonparametric; Treatment Outcome | 2009 |
Valsartan Versus Amlodipine Effect on Left Ventricular Multidirectional Deformation and Adipocytokines Levels in Hypertensive Patients: Speckle Tracking Echocardiography.
Topics: Adipokines; Adiponectin; Adult; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Antihypertensive Agents; Biomarkers; C-Reactive Protein; Calcium Channel Blockers; Echocardiography; Egypt; Female; Humans; Hypertension; Leptin; Male; Middle Aged; Predictive Value of Tests; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha; Valsartan; Ventricular Function, Left; Ventricular Remodeling | 2020 |
2 other study(ies) available for amlodipine and leptin
Article | Year |
---|---|
Effect of amlodipine on insulin resistance & tumor necrosis factor-alpha levels in hypertensive obese type 2 diabetic patients.
Topics: Adolescent; Adult; Aged; Amlodipine; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Female; Homeostasis; Humans; Hypertension; Insulin Resistance; Leptin; Lipids; Middle Aged; Obesity; Prospective Studies; Tumor Necrosis Factor-alpha | 2004 |
Chronic blockade of angiotensin AT₁ receptors improves cardinal symptoms of metabolic syndrome in diet-induced obesity in rats.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Animals; Anti-Obesity Agents; Antihypertensive Agents; Behavior, Animal; Benzimidazoles; Benzoates; Diet, High-Fat; Dietary Sucrose; Drug Therapy, Combination; Energy Intake; Hyperlipidemias; Hypertension; Hypolipidemic Agents; Insulin Resistance; Leptin; Male; Metabolic Syndrome; Obesity; Random Allocation; Rats; Rats, Inbred SHR; Telmisartan; Weight Gain | 2014 |